donepezil elpen 10 mg filmtabletten
donepezil elpen 5 mg filmtabletten
flusalmer s.k. 50250 mcg
k.s.kim international (sk- pharma) ltd., israel - fluticasone propionate; salmeterol as xinafoate - powder for inhalation - salmeterol as xinafoate 50 mcg; fluticasone propionate 250 mcg - salmeterol and other drugs for obstructive airway diseases - flusalmer sk is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate . flusalmer sk is indicated for the symptomatic treatment of patients with copd, with a fev1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who havesignificant symptoms despite regular bronchodilator therapy.
flusalmer s.k. 50500 mcg
k.s.kim international (sk- pharma) ltd., israel - fluticasone propionate; salmeterol as xinafoate - powder for inhalation - salmeterol as xinafoate 50 mcg; fluticasone propionate 500 mcg - salmeterol and other drugs for obstructive airway diseases - flusalmer sk is indicated in the regular treatment of asthma in children and adults, where use of a combination (bronchodilator and inhaled corticosteroid) has been found to be appropriate . flusalmer sk is indicated for the symptomatic treatment of patients with copd, with a fev1 <60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who havesignificant symptoms despite regular bronchodilator therapy.
rovalux film-coated tablets 10mg
pharmakoe pte. ltd. - rosuvastatin calcium eqv rosuvastatin - tablet, film coated - rosuvastatin calcium eqv rosuvastatin 10mg
rovalux film-coated tablets 20mg
pharmakoe pte. ltd. - rosuvastatin calcium eqv rosuvastatin - tablet, film coated - rosuvastatin calcium eqv rosuvastatin 20mg
ezator s.k. 1010 mg
k.s.kim international ltd - atorvastatin as calcium trihydrate; ezetimibe - film coated tablets - ezetimibe 10 mg; atorvastatin as calcium trihydrate 10 mg - atorvastatin and ezetimibe - - prevention of cardiovascular eventsezator s.k. is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs), either previously treated with a statin or not.- hypercholesterolaemiaezator s.k. is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate. • patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- homozygous familial hypercholesterolaemia (hofh)ezator s.k. is indicated as adjunctive therapy to diet for use in adults with hofh. patients may also receive adjunctive treatments (e.g., low-density lipoprotein [ldl] apheresis).
ezator s.k. 1020 mg
k.s.kim international ltd - atorvastatin as calcium trihydrate; ezetimibe - film coated tablets - ezetimibe 10 mg; atorvastatin as calcium trihydrate 20 mg - atorvastatin and ezetimibe - - prevention of cardiovascular eventsezator s.k. is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs), either previously treated with a statin or not.- hypercholesterolaemiaezator s.k. is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate. • patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- homozygous familial hypercholesterolaemia (hofh)ezator s.k. is indicated as adjunctive therapy to diet for use in adults with hofh. patients may also receive adjunctive treatments (e.g., low-density lipoprotein [ldl] apheresis).
ezator s.k. 1040 mg
k.s.kim international ltd - atorvastatin as calcium trihydrate; ezetimibe - film coated tablets - ezetimibe 10 mg; atorvastatin as calcium trihydrate 40 mg - atorvastatin and ezetimibe - - prevention of cardiovascular eventsezator s.k. is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs), either previously treated with a statin or not.- hypercholesterolaemiaezator s.k. is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate. • patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- homozygous familial hypercholesterolaemia (hofh)ezator s.k. is indicated as adjunctive therapy to diet for use in adults with hofh. patients may also receive adjunctive treatments (e.g., low-density lipoprotein [ldl] apheresis).
ezator s.k. 1080 mg
k.s.kim international ltd - atorvastatin as calcium trihydrate; ezetimibe - film coated tablets - ezetimibe 10 mg; atorvastatin as calcium trihydrate 80 mg - atorvastatin and ezetimibe - - prevention of cardiovascular eventsezator s.k. is indicated to reduce the risk of cardiovascular events in patients with coronary heart disease (chd) and a history of acute coronary syndrome (acs), either previously treated with a statin or not.- hypercholesterolaemiaezator s.k. is indicated as adjunctive therapy to diet for use in adults with primary (heterozygous familial and non-familial) hypercholesterolaemia or mixed hyperlipidaemia where use of a combination product is appropriate. • patients not appropriately controlled with a statin alone• patients already treated with a statin and ezetimibe- homozygous familial hypercholesterolaemia (hofh)ezator s.k. is indicated as adjunctive therapy to diet for use in adults with hofh. patients may also receive adjunctive treatments (e.g., low-density lipoprotein [ldl] apheresis).